Preparation for reducing cancer symptoms without treating cancer |
| We claim: 1. A composition useful in inhibiting promotion of adipose degradation and anorexia, ... |
|
N-acetonylbenzamides and their use as fungicides |
| What is claimed is: 1. A compound of the formula: ##STR7## wherein, R.sub.1 and R.sub.3 are each ... |
|
Fungicidal 2-imidazolin-5-ones and 2-imidazoline-5-thiones |
| What is claimed is: 1. A compound having the formula: ##STR87## wherein R.sub.4 is: alkyl having 1 ... |
|
Fungicidal active compound combinations |
| We claim: 1. A fungicidal composition comprising synergistic effective amounts of a valinamide ... |
|
Fungicidal compositions containing N-acetonylbenzamides |
| We claim: 1. A fungicidal composition comprising synergistic fungicidally effective amounts of (a) ... |
|
Methods for stabilizing ingredients within cosmetics, personal care and household products |
| What is claimed is: 1. A method of stabilizing at least one photosensitive poly-unsaturated and/or ... |
|
Topical anti-inflammatory composition and method |
| The present invention is a composition and method for topically treating inflammation caused by a ... |
|
Pharmaceutical compositions and preparations thereof |
| OF THE INVENTION The invention and its various aspects will now be described hereunder. Examples 1 ... |
|
Pain reliever and method of use |
| OF THE PREFERRED EMBODIMENTS Capsaicin is trans-8-methyl-N-vanillyl-5 nonenamide, a naturally ... |
|
|
Pharmaceutical compositions containing at least one NSAID having increased bioavailability
| Details |
Inventors: Singh, Amarjit; Jain, Rajesh;
Assignee: Panacea Biotec Limited (New Delhi, IN)
Primary Examiner: Spivack; Phyllis G.
Assistant Examiner:
Attorney, Agent or Firm: Oblon, Spivak, McClelland, Maier & Neustadt, P.C.
A novel composition for increasing the bioavailability of Non-steroidal Anti-inflammatory Drugs (NSAIDs), particularly those belonging to the category which exhibits its activity by selectively inhibiting cyclooxygenases-II (COX-II) and/or lipooxygenases, is disclosed. The composition is characterized in having clinically significant increased bioavailability when compared to the known compositions of the drugs. The pharmaceutical compositions comprise NSAIDs and Piperine, as herein disclosed. Enhanced bioavailability of NSAIDs results in the reduction of both dosages and dose-related side effects. |
|
DETAILED DESCRIPTION OF THE INVENTION The incorporation of Piperine, its metabolites or structural analogues or isomers thereof with NSAIDs particularly Nimesulide or derivatives thereof results in a synergistic composition having unexpected increased bioavailability of NSAIDs particularly Nimesulide and derivatives thereof. Therefore the invention does not involve simple mixing of the components. It is also to be noted that Piperine or has no pharmacological properties but when mixed with NSAIDs particularly Nimesulide or derivatives thereof results in a synergistic effect on said NSIADs particularly Nimesulide causing enhanced activity and bio-availibilty thereof. Piperine, (E, E) 1-[5-(1,3-benzodioxyl-5-yl)-1-oxo-2,4-pentadenyl] piperidine is the main constituent of many Piper species. It is mostly obtained from Piper longum (3-5%) or Piper nigrum (3-9%) which are cultivated commercially. Piperine has the formula: ##STR2## Examples of its metabolites are as follows: ##STR3## Piperine as a parent molecule and/or one or more of its metabolites and/or analogues thereof may have a role in enhancing bio-availability of drugs. Examples of Piperine analogues are derivatives in which the piperidine ring is substituted, e. g. by an amino group, or esters (e. g. C. sub. 1-6 alkyl esters) of metabolites containing an OH group. Piperine forms monoclinic prisms from ethanol mp 130. degree. C. It is tasteless at first but induces a burning sensation after a few seconds. It is neutral to litmus (pKa 12. 22). It is soluble in benzene, chloroform, ether, ethyl acetate, dichloromethane, alcohol, acetic acid and insoluble in water, pet. ether. On alkaline hydrolysis it furnishes a base piperidine and the acid viz. piperic acid, mp 216. degree. C. It may be synthesized by condensing the two components under proper conditions. It has the following spectral characteristics: UV (methanol): max 340 mu (32,000). IR(KBr): 1633, 1610, 1580, 1510, 1440, 1250, 1190, 1130, 1030, 995, 930, 842 cm. sup. -1. Piperine is commercially available
|
| Related patents |
|
|
Controlled release compositions for macrolide antimicrobial agents
OF THE INVENTION In the context of the present invention a number of terms have been used. In order to provide a clear and consistent understanding of the specification,...
|
|
|
Novel skin-whitening agent
OF THE INVENTION The active ingredient in the skin-whitening agent of the present invention is the dithiazole-monomethine-cyanine compound of the formula (I) wherein R ...
|
|
|
Microcapsule, treating liquids containing the same, and textile structure having microcapsules adhering thereto
We claim: 1. A textile structure having microcapsules adhered thereto by a binder, said microcapsules having a particle diameter in the range of 2.about.40 .mu.m and a ...
|
|
|
Water-in-stable L-ascorbic acid derivative and a method for preparation thereof, and a skin-whitening cosmetic composition containing the same
OF THE INVENTION L-ascorbic acid derivative provided by the present invention is 2-(3-Aminopropane phosphoric acid)-L-ascorbate represented by a following general ...
|
|
|
Skin whitener composition containing mercaptodextran
OF THE INVENTION In accordance with the present invention, a skin whitener composition is provided and comprises mercaptodextran as an active ingredient. In the ...
|
|
|
Composition for external application containing a .beta.-1,6-branched-.beta.-1,3-glucan
OF THE INVENTION Schizophyllum commune Fr. is woody rotting fungi belonging to Agaricales Tricholomataceae Schizophyllum of basidiomycetes in classification by Singer R....
|
|
|
Method of hydrolyzing defatted jojoba meal with protease enzymes
The present invention is directed to a new form of jojoba protein, namely hydrolyzed jojoba protein and derivatives thereof, as well as uses of such protein products in ...
|
|
|
Use of amidoamines to treat or prevent acanthamoeba and fungal infections
What is claimed is: 1. A method of treating infections attributable to Acanthamoeba, fungi or a combination of Acanthamoeba and fungi, which comprises applying a topical ...
|
|
|
1-(5-Trifluoromethyl-1, 3,4-thiadiazol-2-yl)-3-methyl-5-acetyloxy-1,3-imidazolidin-2-one
I claim: 1. The compound 1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)-3-methyl-5-acetyloxy-1,3-imida zolidin-2-one.
Description:
This invention relates to a ...
|
|
|
Confectioneries containing stabilized highly odorous flavor component delivery systems
AND PREFERRED EMBODIMENT It is known that food stimulates the sense of smell, taste and touch. The interpretation and characterization of this stimuli is subjective and ...
|
|
|